Down‐regulation of EMI1 interferes with DNA synthesis in varieties of tumour, such as glioblastoma and breast cancer, inhibiting cancer cell growth and enhancing its sensitivity to chemotherapy and radiation therapy.54 This evidence concerns the gene FBXO5 and breast carcinoma.